TORL BioTherapeutics, LLC
Iris S. currently serves as the Vice President and Head of Clinical Operations at TORL Biotherapeutics, LLC, since October 2023. Prior to this role, Iris held various positions at IGM Biosciences, Inc., including Senior Director and Director of Clinical Operations from April 2019 to August 2023. Iris also worked at Genentech as a Senior Global Clinical Trial Leader and Global Clinical Trial Leader from July 2015 to April 2019. Earlier experience includes positions at Translational Research In Oncology as a Monitoring Resources Training Associate and Clinical Research Associate, as well as serving as the Lead Clinical Research Coordinator at UCSF Helen Diller Comprehensive Cancer Center from 2009 to 2011. Iris began the career at Retinal Consultants Medical Group, Inc. as a Clinical Research Coordinator from 2005 to 2009. Iris holds a Bachelor of Science degree from UC Davis.
This person is not in any teams
This person is not in any offices
TORL BioTherapeutics, LLC
1 followers
A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment. TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients. TORL has currently 3 therapeutics in Ph1 clinical trials in indications such as NSCLC, gastric, pancreatic and ovarian cancers